Stereotactic body radiotherapy for localized prostate cancer – 5-year efficacy results
Abstract Background The use of stereotactic body radiotherapy (SBRT) as the primary treatment modality in clinically localized prostate cancer (PCa) is emerging. The aim of the study was to analyze the long-term results of PCa patients treated with SBRT. Methods This non-selected, real-life patient...
Main Authors: | Kristiina Vuolukka, Päivi Auvinen, Erno Tiainen, Jan-Erik Palmgren, Janne Heikkilä, Jan Seppälä, Sirpa Aaltomaa, Vesa Kataja |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-07-01
|
Series: | Radiation Oncology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13014-020-01608-1 |
Similar Items
-
Incidence of subsequent primary cancers and radiation-induced subsequent primary cancers after low dose-rate brachytherapy monotherapy for prostate cancer in long-term follow-up
by: Kristiina Vuolukka, et al.
Published: (2020-05-01) -
Editorial: The Evolving Landscape of Stereotactic Body Radiation Therapy for the Management of Prostate Cancer
by: Seth R. Blacksburg, et al.
Published: (2020-12-01) -
Stereotactic Body Radiotherapy as Treatment for Organ Confined Low and Intermediate Risk Prostate Carcinoma, a Seven Year Study
by: Alan Jay Katz, et al.
Published: (2014-09-01) -
Comparison of quality of life after stereotactic body radiotherapy and surgery for early-stage prostate cancer
by: Katz Alan, et al.
Published: (2012-11-01) -
Stereotactic radiotherapy with focal boost for intermediate and high-risk prostate cancer: Initial results of the SPARC trial
by: Luke Nicholls, et al.
Published: (2020-11-01)